In This Article

The short answer: Fasting insulin is the most sensitive early marker of metabolic dysfunction: it rises years before fasting glucose becomes abnormal or A1C enters the prediabetic range. HOMA-IR (a calculation from fasting insulin and fasting glucose) quantifies insulin resistance on a single number. The optimal fasting insulin is below 8 uIU/mL; HOMA-IR below 1.5 is excellent, 2.0-2.9 is borderline, and above 3.0 indicates significant insulin resistance. Most standard metabolic panels do not include fasting insulin. You have to request it.



Read key takeaways →

What Fasting Insulin Actually Measures

Fasting glucose tells you how much glucose is in your blood after an overnight fast. Fasting insulin tells you how hard your pancreas is working to keep that glucose in a normal range. These are very different questions.

A person with fasting glucose of 92 mg/dL and fasting insulin of 4 uIU/mL is metabolically healthy: their glucose is normal, and it requires very little insulin to maintain it. A person with fasting glucose of 94 mg/dL and fasting insulin of 22 uIU/mL has a very different profile: their glucose is also "normal" by standard reference ranges, but their pancreas is working roughly five times as hard to achieve that result. That hyperinsulinemia is the early signal of insulin resistance, before glucose itself becomes abnormal.

Why fasting glucose alone misses early insulin resistance

Metabolic compensation begins

Insulin rises first

Years later

Glucose rises

Standard diagnosis

Prediabetes detected

Insulin resistance can be present for 10-15 years before fasting glucose reaches the prediabetic threshold of 100 mg/dL. Measuring insulin catches the process earlier, when lifestyle intervention is most effective.

Bikman (Brigham Young University) has written extensively on insulin's role as a metabolic master regulator. Chronically elevated insulin promotes fat storage, suppresses fat burning, drives inflammation. Critically, it is downstream of the behaviors that are actually treatable: diet quality, movement, sleep, and stress. Fasting insulin gives you a number that reflects the sum of those behaviors over the preceding weeks to months.

HOMA-IR: What the Number Means

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculation that uses both fasting insulin and fasting glucose to estimate insulin resistance. It was developed by Matthews et al. (1985, Diabetologia) and remains one of the most widely used surrogate measures of insulin resistance in research and clinical practice.

The HOMA-IR formula

HOMA-IR = (Fasting Insulin [uIU/mL] × Fasting Glucose [mg/dL]) ÷ 405

If glucose is in mmol/L: HOMA-IR = (Fasting Insulin [uIU/mL] × Fasting Glucose [mmol/L]) ÷ 22.5

HOMA-IR interpretation ranges

Below 1.0

Excellent insulin sensitivity

Cells are highly responsive to insulin. Pancreas works minimally to maintain glucose control. Typical of athletes with consistent Zone 2 training and low processed food intake.

1.0 to 1.9

Good, normal range

Healthy insulin sensitivity. No action required; this is the expected range for a metabolically healthy adult with reasonable diet and movement habits.

2.0 to 2.9

Borderline: watch

Early insulin resistance. Glucose is likely still normal, but the pancreas is working harder. Lifestyle intervention is highly effective at this stage. Diet quality, Zone 2 training, and sleep are the primary levers.

3.0 to 4.9

Elevated: insulin resistance

Meaningful insulin resistance. Risk for prediabetes, metabolic syndrome, and cardiovascular disease is elevated. Fasting glucose is likely approaching 95-99 mg/dL. Intervention required; consider clinical evaluation.

5.0 and above

High: significant dysfunction

Significant metabolic dysfunction. Strong predictor of type 2 diabetes onset. Clinical evaluation and potentially pharmacological intervention alongside lifestyle changes.

These are functional targets, not standard laboratory reference ranges. Most labs list "normal" fasting insulin as anything below 25 uIU/mL, a range that would include significant insulin resistance. The functional optimal below 8 uIU/mL (and ideally below 5 uIU/mL for athletes) is based on outcomes research, not lab calibration conventions.

What Drives Insulin Resistance (and What Reverses It)

Insulin resistance is not primarily a genetic condition for most people. It develops from the sustained interaction of several lifestyle factors that chronically elevate insulin and overwhelm cellular insulin signaling pathways.

Common Misconception

Insulin resistance is not simply caused by "eating too much sugar." The mechanism involves chronically elevated insulin from any combination of high refined carbohydrates, excess caloric intake, physical inactivity, sleep disruption, and visceral fat accumulation. Fruit, despite containing fructose, does not drive insulin resistance in the context of a whole-food diet. Ultra-processed foods, which combine rapidly absorbed carbohydrates with hyperpalatable ingredients that promote overconsumption, are the stronger driver in population data.

Excess visceral fat
Visceral adipose tissue releases free fatty acids and pro-inflammatory cytokines (TNF-alpha, IL-6) that impair insulin receptor signaling in muscle and liver. Waist circumference above 40 inches (men) or 35 inches (women) is a strong insulin resistance predictor independent of BMI.
Physical inactivity
Skeletal muscle is the primary site of glucose disposal. GLUT4 transporter expression in muscle decreases with sedentary behavior, requiring more insulin to move glucose into cells. Even a single 45-minute walk substantially improves insulin sensitivity for the following 24 hours (Wojtaszewski et al., 2000).
Sleep deprivation
One week of sleep restriction to 5 hours per night reduces insulin sensitivity by approximately 25% in healthy adults (Spiegel et al., 1999, Lancet). Cortisol elevation and growth hormone suppression from poor sleep both impair insulin signaling.
Chronic stress
Cortisol promotes gluconeogenesis (liver glucose production) and impairs GLUT4-mediated glucose uptake. Chronic cortisol elevation directly drives HOMA-IR upward independent of diet.
Ultra-processed food
High glycemic load, absence of fiber, and hyperpalatable formulation promote rapid glucose absorption and chronic hyperinsulinemia. Hall et al. (2019, Cell Metabolism) showed 500 cal/day spontaneous overconsumption with ultra-processed vs. whole-food diets.

The reversibility of insulin resistance through lifestyle intervention is well-documented. Colberg et al. (2010, Diabetes Care) reviewed the exercise evidence: regular aerobic exercise improves insulin sensitivity within days through GLUT4 upregulation, and resistance training adds additional benefit by increasing muscle mass, the primary glucose disposal tissue. A combination of Zone 2 aerobic training and strength training produces the largest improvements.

How to Test and What to Ask For

Most standard metabolic panels, including those ordered with routine physicals, do not include fasting insulin. Fasting glucose, A1C, and basic chemistry are standard; fasting insulin is not. You have to specifically request it.

What to request (and what to ask at the same time)

  • Fasting insulin: The primary test. Ask specifically by name. Most labs offer it; some physicians don't order it routinely. Direct testing options like Function Health or Ulta Lab Tests include it without a physician order.
  • Fasting glucose: Required to calculate HOMA-IR. Almost always included in comprehensive metabolic panels.
  • HbA1c: Reflects average blood glucose over 3 months. Useful alongside HOMA-IR for the complete picture. Optimal range is below 5.4%; prediabetic threshold is 5.7-6.4%.
  • Fasting triglycerides: Strongly correlated with insulin resistance. Elevated triglycerides above 100 mg/dL alongside low HDL is a reliable surrogate marker even without direct insulin measurement. The triglyceride:HDL ratio above 3.0 is a strong insulin resistance signal (McLaughlin et al., 2003).
  • Fasting state: At minimum 8 hours, ideally 10-12 hours. No coffee (even black: it raises cortisol transiently). Water is fine. Morning tests before activity are most reproducible.

Testing frequency: annually is a reasonable baseline for healthy adults who want to track metabolic trajectory over time. Every 6 months makes sense when actively intervening: diet change, new training protocol, significant weight loss, to confirm the intervention is working. For context, HOMA-IR responds to lifestyle changes within 4-12 weeks, making it a useful feedback marker for intervention effectiveness.

What to Do with a High Result

If your HOMA-IR comes back at 2.5 or higher, the intervention hierarchy is clear and well-supported. Ranked by evidence strength and impact magnitude:

1

Reduce visceral fat through caloric deficit + strength training

Visceral fat reduction produces the largest HOMA-IR improvements. A moderate caloric deficit (300-500 cal/day) combined with resistance training preserves muscle while reducing the visceral fat that drives inflammatory signaling. Targeting 0.5-1% body weight loss per week is sustainable and preserves muscle.

2

Add Zone 2 aerobic training (150+ min/week)

Zone 2 training upregulates GLUT4 transporters in skeletal muscle, directly improving glucose disposal independent of weight loss. Even in the absence of caloric restriction, regular aerobic exercise improves HOMA-IR. San Millan's work suggests 150-180 min/week as the minimum effective dose for meaningful metabolic adaptation.

3

Shift to whole foods, eliminate ultra-processed carbohydrates

Whole foods, including vegetables, legumes, whole grains, protein from animal and plant sources, produce a lower and slower insulin response than processed equivalents with equivalent calories. Dietary fiber slows glucose absorption and feeds gut bacteria that produce short-chain fatty acids, which improve insulin sensitivity through AMPK activation. This is not about eliminating carbohydrates: it's about food quality within carbohydrate intake.

4

Fix sleep (7-9 hours, consistent timing)

Sleep deprivation reduces insulin sensitivity by 20-25% within a week. Improving sleep duration and consistency to 7-9 hours with a consistent wake time addresses both the direct cortisol-driven insulin impairment and the appetite dysregulation (ghrelin/leptin disruption) that drives overconsumption. For an overview of the key sleep metrics and what they mean, see that guide.

5

Reduce chronic stress load

Cortisol chronically elevates blood glucose via gluconeogenesis and impairs insulin receptor signaling. Stress management is metabolic intervention. Zone 2 exercise itself reduces cortisol load (Sapolsky, Stanford); managing morning cortisol patterns is worth understanding alongside the fasting insulin picture.

Re-test after 12 weeks of consistent implementation. A 30-50% reduction in HOMA-IR is achievable in that time frame through lifestyle intervention alone, depending on starting point and adherence. If HOMA-IR remains above 3.0 despite genuine sustained effort, a clinical evaluation for secondary causes (sleep apnea, thyroid dysfunction, PCOS, medications that impair insulin sensitivity) is warranted.

Frequently Asked Questions

My fasting glucose is normal at 88 mg/dL. Do I still need to check fasting insulin?

Yes, this is exactly the scenario the scenario where fasting insulin matters most. A normal fasting glucose with an elevated fasting insulin (e.g., 18-22 uIU/mL) is the classic early insulin resistance pattern. The glucose looks normal because the pancreas is compensating with excess insulin. This compensated insulin resistance can persist for a decade or more before fasting glucose begins to rise. Catching it with a fasting insulin test is the whole point.

What's the difference between HOMA-IR and HOMA-B (beta cell function)?

The HOMA model produces two outputs from the same inputs. HOMA-IR estimates insulin resistance. HOMA-B estimates beta cell function: how well the insulin-producing beta cells in the pancreas are working. Most clinical and self-tracking applications use HOMA-IR. HOMA-B becomes relevant in the context of type 2 diabetes progression, where beta cell exhaustion is a separate concern from insulin resistance.

Is the triglyceride:HDL ratio a reliable substitute for HOMA-IR if I can't get insulin tested?

It's a useful surrogate, not a replacement. McLaughlin et al. (2003) found that a triglyceride:HDL ratio above 3.0 was a strong predictor of insulin resistance, with a sensitivity of about 65% and specificity of 85% for identifying HOMA-IR above 3.0. So a high ratio is meaningful, but a normal ratio doesn't rule out insulin resistance. If you can get one additional test beyond the standard lipid panel, make it fasting insulin.

How quickly can HOMA-IR improve with lifestyle changes?

Faster than most people expect. A single 45-minute aerobic session improves insulin sensitivity for the following 24 hours (acute effect). Over 4-8 weeks of consistent Zone 2 training, GLUT4 expression increases in muscle tissue (structural adaptation). Diet quality changes show HOMA-IR improvements within 4-6 weeks in intervention studies. Weight loss of 5-10% of body weight produces proportionally larger improvements in visceral fat and HOMA-IR than the scale number suggests. Re-test at 12 weeks to assess trajectory.

My doctor says my labs are normal. Should I be pushing for fasting insulin?

Yes, if you're optimizing rather than just avoiding disease. Standard care uses reference ranges calibrated to detect disease, not to identify optimal function. A fasting insulin of 22 uIU/mL is "normal" by most labs' reference ranges but represents significant insulin resistance by functional medicine standards. Framing the request as wanting to understand your metabolic baseline and track it over time is usually sufficient. Direct testing options (Function Health, Ulta Lab Tests, LabCorp) let you order it without a physician order in most US states.

What to Remember

  • Fasting insulin rises years before fasting glucose becomes abnormal. It is the most sensitive early marker of insulin resistance available in standard lab testing, and most routine physicals don't include it. You have to specifically request it.
  • HOMA-IR below 1.5 is excellent; 2.0-2.9 is borderline; 3.0 and above indicates meaningful insulin resistance. These are functional targets from outcomes research, not standard lab reference ranges.
  • The triglyceride:HDL ratio above 3.0 is a reliable surrogate for insulin resistance when direct insulin testing is unavailable, but it misses roughly 35% of cases. A direct fasting insulin test is preferable.
  • Insulin resistance is largely reversible through lifestyle. Zone 2 training upregulates GLUT4 in muscle within weeks; caloric restriction plus strength training reduces visceral fat; sleep improvement cuts cortisol-driven insulin impairment. Re-test at 12 weeks.
  • Sleep deprivation reduces insulin sensitivity by approximately 25% in one week (Spiegel et al., 1999). Sleep is not a soft metabolic intervention: it directly changes the number you're trying to improve.
  • Test fasting: 10-12 hours, no coffee, no exercise that morning. Morning tests are the most reproducible. Acute stress, caffeine, and recent exercise all transiently affect insulin and glucose, skewing the calculation.

Track your metabolic baseline over time with Protocol

Protocol helps you connect your lab biomarkers with your daily wearable data so you can see how your sleep, training load, and food choices are moving your HOMA-IR and fasting insulin over time.

Get started free

References

Key Researchers

  • Benjamin Bikman (Brigham Young University) Insulin resistance researcher and author of Why We Get Sick (2020). His work focuses on insulin as a master metabolic regulator and the downstream consequences of chronic hyperinsulinemia on disease risk.
  • Gerald Reaven (Stanford University) Pioneered the clinical concept of insulin resistance syndrome (Syndrome X, now Metabolic Syndrome) in the 1980s, establishing that insulin resistance precedes and drives type 2 diabetes, hypertension, and dyslipidemia.
  • David Matthews (University of Oxford) Lead developer of the HOMA model (1985), which created a validated surrogate measure of insulin resistance from fasting insulin and glucose values. HOMA-IR remains the standard research and clinical tool for assessing insulin resistance without an insulin clamp.

Key Studies

  • Matthews et al. (1985) Diabetologia. Original paper introducing the HOMA model for estimating insulin resistance and beta cell function from fasting insulin and glucose. Validated against the gold-standard euglycemic-hyperinsulinemic clamp.
  • Spiegel et al. (1999) Lancet. Sleep restriction to 4 hours per night for 6 days reduced insulin sensitivity by approximately 30% and elevated cortisol in healthy young men, demonstrating the direct metabolic cost of short sleep.
  • McLaughlin et al. (2003) Diabetes Care. Established the triglyceride:HDL ratio above 3.0 as a surrogate marker for insulin resistance, with sensitivity and specificity sufficient for clinical screening when direct insulin measurement is unavailable.
  • Colberg et al. (2010) Diabetes Care. Comprehensive review of exercise and insulin resistance. Documented that aerobic exercise improves insulin sensitivity within 24 hours through GLUT4 upregulation, with resistance training adding independent benefit through increased muscle mass.